Insiders · Profile

Matrix Capital Management Company, LP

10% owner at Aura Biosciences · 10% owner at Zentalis Pharmaceuticals. Filing since 2 Nov 2021. CIK 0001410830

Company
Date
Role
Action
Shares
Amount
Of holding
7 May 2026
10% owner
Sold at will
6,922,870
$39.04M
100%
15 Dec 2025
10% owner
Sold at will
7,500,000
$9.98M
53.7%
9 Nov 2023
10% owner
Bought
1,560,000
$14.04M
29.1%
20 Jun 2023
10% owner
Bought
4,760,000
$107.86M
51.7%
5 Dec 2022
10% owner
Bought
1,250,000
$15.00M
30.4%
2 Nov 2021
10% owner
Bought
1,785,000
$24.99M
76.7%
6 decisions on file.